Pancreatic Beta Cell Differentiation Without Growth Factors
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating pancreatic beta cells from pluripotent stem cells are costly and inefficient due to the use of high concentrations of expensive growth factors, and they require optimization for each batch, making them impractical for widespread application, especially in treating type 1 diabetes.
Innovation Solution
A growth-factor free, defined culture condition method is employed to generate pancreatic progenitor and beta cells by modulating specific signaling pathways using small molecules, including Wnt, BMP, Hedgehog, Retinoic Acid, Notch, and TGF-beta signaling, without the use of serum or growth factors, allowing for high efficiency and cost-effectiveness.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If high concentrations of expensive growth factors are used to generate pancreatic beta cells from pluripotent stem cells, then functional beta cells can be produced, but the manufacturing cost becomes prohibitively high and the process becomes impractical for widespread application
Solution Approach 1:
The patent removes growth factors from the differentiation medium, extracting the expensive component that drives beta cell production. The invention achieves this by using small molecule inhibitors (CHIR99021 for Wnt pathway activation, Dorsomorphin for BMP pathway inhibition) to replace growth factor-dependent signaling, thereby eliminating the need for expensive growth factors while maintaining beta cell generation capability
Solution Approach 2:
The patent changes the chemical parameters of the differentiation medium by substituting growth factors with small molecule compounds. Specifically, it uses CHIR99021 (a GSK-3 inhibitor) to activate Wnt signaling and Dorsomorphin (a BMP inhibitor) to block BMP signaling, fundamentally altering the signaling landscape to achieve growth factor-independent beta cell differentiation
2Reliability
If complex step-wise protocols with multiple growth factors are used to guide hPSC differentiation through successive stages, then functional beta cells can be generated, but the process complexity increases and requires optimization for each batch
Solution Approach 1:
The patent extracts and removes multiple growth factors (Activin A, FGF2, FGF10, FGF7) from the differentiation protocol, simplifying the medium composition. By using small molecule inhibitors instead, it reduces the number of components that need to be optimized and controlled, thereby reducing protocol complexity while maintaining differentiation success
Solution Approach 2:
The patent changes the protocol from growth factor-based signaling to small molecule-based signaling. This parameter change simplifies the protocol because small molecules have more predictable and stable effects, require less optimization, and can be used at defined concentrations without batch-to-batch variability inherent in biological growth factors
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method produces functional beta cells that mimic mature beta cells, capable of insulin secretion in response to glucose stimulation, and can be scaled up for clinical applications, providing a cost-effective and reproducible source of beta cells for diabetes treatment.
Implementation Method 1
modulating specific signaling pathways using small molecules, including Wnt, BMP, Hedgehog, Retinoic Acid, Notch, and TGF-beta signaling
Data Source
AI summary
Provided are methods, compositions and kits for generating beta cells from pluripotent stem cells under growth-factor free, defined culture conditions. The beta cells can be generated under conditions that are free of animal products. The generated beta cells secrete insulin, not glucagon, and the amount of insulin secreted is dependent upon the level of glucose stimulus.